Impact of a vancomycin restriction policy on use and cost of vancomycin and incidence of vancomycin-resistant Enterococcus

Annals of Pharmacotherapy

Volumn 31, Issue 9, 1997, Pages 970-973

  Morgan, Amy S ^a   Brennan, Patrick J ^a   Fishman, Neil O ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Vancomycin; Vancomycin resistant Enterococcus

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; DRUG COST; ENTEROCOCCUS; HEALTH CARE POLICY; HOSPITAL PHARMACY; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0030799443     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100902     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993;42:597-9.
2. Boyle JF, Soumakis SA, Rendo JA, Herrington JA, Gianarkis DG, Thurberg BE, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993;31:1280-5.
3. Morris JG, Shay DK, Hebden JN, McCarter RJ, Perdue BE, Jarvis W, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Ann Intern Med 1995;123:250-9.
4. Boyce JM, Opal SM, Chow JW, Zervos MJ, Potter-Bynoe G, Sherman CB, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994; 32:1148-53.
5. Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995;172:993-1000.
6. Moreno F, Grota P, Crisp C, Magnon K, Melcher GP, Jorgensen JH, et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995;21:1234-7.
7. Byers KE, Titus MG, Alexander CH, Durbin LJ, Simonton B, Duani DK, et al. A hospital outbreak of vancomycin-resistant Enterococcus faecium controlled with intensive surveillance culturing and gown and glove isolation (abstract). The 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 17, 1995.
8. Anglim AM, Klym MB, Byers KE, Farr BM. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium (abstract). The 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 17, 1995.
9. Montecalvo MA, Horowitz HW, Nadelman R, Nowakowski J, Andryshak C, Colbi D, et al. Controlling IV vancomycin on an oncology unit by infectious diseases consultation (abstract). The 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 17, 1995.
10. Singer MV, Sands KE. Vancomycin control measures at a tertiary care hospital: impact on volume and appropriateness of use (abstract). The 33rd Annual Meeting of the Infectious Diseases Society of America, San Francisco, CA, September 17, 1995.
11. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance. MMWR Morb Mortal Wkly Rep 1994;44(RR-12):1-13.
12. Norris AH, Reilly JP, Edelstein PH, Brennan PJ, Schuster MG. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infection. Clin Infect Dis 1995;20:1137-44.
13. Sastry V, Brennan PJ, Levy MM, Fishman N, Friedman AJL, Naji A, et al. Vancomycin-resistant enterococci: an emerging pathogen in immunosuppressed transplant recipients. Transplant Proc 1995;27:954-5.
14. Johnson SV, Hoey LL, Vance-Bryan K. Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention. Pharmacotherapy 1995;15:579-85.
15. Evans ME, Kortas KJ. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines. Infect Control Hosp Epidemiol 1996;17:356-9.